Medicines Company (MDCO +1.9%) moves up today after agreeing to acquire privately held Incline...

|About: The Medicines Company (MDCO)|By:, SA News Editor

Medicines Company (MDCO +1.9%) moves up today after agreeing to acquire privately held Incline Therapeutics for $185M plus potential milestone payments. The acquisition gives MDCO access to the development of a disposable and needleless patient-controlled analgesia system for postoperative pain management in hospitals. Additionally, the company also reached a licensing agreement with Bristol-Myers Squibb (BMY +0.6%) on its Recothrom topical treatment to control bleeding during surgery.